ACEP ID:

Left Arrow Right Arrow Down Arrow Up Arrow Left Arrow Right Arrow Down Arrow Up Arrow
Section IconNitrous Oxide
Overview
Nitrous oxide (NO) produces analgesia and anxiolysis with a rapid onset of action (<60 sec) and rapid elimination.1-3
It is administered in combination with oxygen (O2) via mask or nasal hood.
It can be administered at the bedside using approved mobile devices.
It is especially useful in fast-track areas when analgesia with anxiolysis is indicated but cardiac monitoring is not available.
Indications
Any painful procedure in a patient older than 1 year4-7
Contraindications
Altered level of consciousness2,8
Any active pathology involving confined spaces that can be affected by pressure changes (eg, otitis media, sinusitis, bowel obstruction, pneumothorax, pneumocephaly)
Chronic severe vitamin B12 deficiency
COPD or severe active asthma
First- and second-trimester pregnancy
NO is associated with increased risk of spontaneous abortion in dental hygienists who administer gas more than 3 hours/week without proper scavenging equipment.9
Equipment & Dosing
NO and O2 tanks or delivery systems.
Nasal hood or full-face mask.
If available, an approved mobile unit that can transport the equipment to any part of the ED.
  • Some hold only NO tanks and must be plugged in to wall oxygen.
  • Some require a hose plugged into wall suction for scavenging, a safety feature that prevents NO exposure to clinicians.1,2
Procedure & Administration
Start pulse oximetry monitoring.
  • No NPO requirements, cardiac monitoring, or peripheral IV is necessary.
  • NO administered as a sole agent is not considered procedural sedation. Its use should not require a nurse at the bedside, but institutional guidelines vary and should prevail.
Apply the mask or nasal hood to the patient’s face. Either the patient or a staff member can hold the mask in place.
Turn on the unit and allow the patient to breathe O2 for 15 to 30 seconds, then start NO administration. NO and O2 are administered simultaneously.10
Titrate NO by 10% to 20% every 30 to 60 seconds to desired effect.
Adjust the amount of NO to a maximum of 70% concentration, always allowing for 30% O2.
Adjust the flow of O2 depending on the patient’s tidal volume requirements, but the percentage of NO will not change with adjustments in O2.
Engage the patient in conversation. If the patient is unable to converse, turn off or titrate down the gas.
Begin the procedure once a desired level of anxiolysis and analgesia is achieved.
When the procedure is finished, discontinue the NO and allow the patient to breathe 100% O2 for 1 minute.
Remove the breathing circuit. Have the patient stay seated and breathe room air for 1 to 2 minutes.
Discharge the patient. No additional monitoring is necessary.
Complications
Claustrophobia due to full face mask
Dizziness
Nausea/vomiting
Charting & Documentation
NO as a single agent is considered an analgesic similar to acetaminophen, ibuprofen, or oxycodone. Although no specific consent is needed, discuss the use of gas with the patient prior to administration and document the conversation.
Order NO as a medication in the EMR and document its use as the analgesic used in the procedure.
Special Considerations
There is abuse potential for NO by patients and practitioners, so the machine should be monitored and accounted for at all times.
If using NO in addition to other CNS-depressing medications for pain, full cardiac monitoring is recommended: combination treatment can be considered procedural sedation.
Discharge Procedure
The patient can drive after the procedure and has no restrictions.
Where to Learn More
References
  1. Becker DE, Rosenberg M. Nitrous oxide and the inhalation anesthetics. Anesth Prog. 2008;55(4):124-130.
  2. Huang C, Johnson N. Nitrous oxide, from the operating room to the emergency department. Curr Emerg Hosp Med Rep. 2016;4:11-18.
  3. Stengvist O. Nitrous oxide kinetics. Acta Anaesthesiol Scand. 1994;38(8):757-760.
  4. Babl FE, Oakley E, Seaman C, et al. High-concentration nitrous oxide for procedural sedation in children: adverse events and depth of sedation. Pediatrics. 2008;121(3):e528-e532.
  5. O’Reilly JE, Roth GI, Matheny JL, et al. The effects of nitrous oxide administration in the healthy elderly: NO elimination and alveolar CO. Anesth Prog. 1983;30(6):187-192.
  6. Furuya A, Ito M, Fukae T, et al. The effective time and concentration of nitrous oxide to reduce venipuncture pain in children. J Clin Anesth. 2009;21(3):190-193.
  7. Pasaron R. Burnweit C, Zerpa J, et al. Nitrous oxide procedural sedation in non-fasting pediatric patients undergoing minor surgery: a 12-year experience with 1,058 patients. Pediatr Surg Int. 2015;31(2):173-180.
  8. Duncan GH, Moore P. Nitrous oxide and the dental patient: a review of adverse reactions. J Am Dent Assoc. 1984;108(2):213-219
  9. Rowland AS, Baird DD, Shore DL, et al. Nitrous oxide and spontaneous abortion in female dental assistants. Am J Epidemiol 1995;141:531-538.
  10. Kaviani N, Birang R. Evaluation of need to pulse oximetry monitoring during inhalation sedation for periodontal treatments. Dental Research J. 2006;3(1) 1-5.

Watch the reference video

  Back To Top
[ Feedback → ]